Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

Paola Minetto; Fabio Guolo; Marino Clavio; Annalisa Kunkl; Nicoletta Colombo; Enrico Carminati; Giuseppina Fugazza; Simona Matarese; Daniela Guardo; Filippo Ballerini; Carmen Di Grazia; Anna M. Raiola; Antonia Cagnetta; Michele Cea; Maurizio Miglino; Roberto M. Lemoli; Marco Gobbi

doi:10.1111/bjh.15106

Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

Paola Minetto, Fabio Guolo, Marino Clavio, Annalisa Kunkl, Nicoletta Colombo, Enrico Carminati, Giuseppina Fugazza, Simona Matarese, Daniela Guardo, Filippo Ballerini, Carmen Di Grazia, Anna M. Raiola, Antonia Cagnetta, Michele Cea, Maurizio Miglino, Roberto M. Lemoli, Marco Gobbi

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	British Journal of Haematology
DOIs	https://doi.org/10.1111/bjh.15106
Publication status	Accepted/In press - Jan 1 2018

Keywords

Acute myeloid leukaemia
Flow cytometry
Fludarabine
Fludarabine, cytarabine, idarubicin
Minimal residual disease

ASJC Scopus subject areas

Hematology

Access to Document

10.1111/bjh.15106

Cite this

Minetto, P., Guolo, F., Clavio, M., Kunkl, A., Colombo, N., Carminati, E., Fugazza, G., Matarese, S., Guardo, D., Ballerini, F., Di Grazia, C., Raiola, A. M., Cagnetta, A., Cea, M., Miglino, M., Lemoli, R. M., & Gobbi, M. (Accepted/In press). Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information. British Journal of Haematology. https://doi.org/10.1111/bjh.15106

Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information. / Minetto, Paola; Guolo, Fabio; Clavio, Marino; Kunkl, Annalisa; Colombo, Nicoletta; Carminati, Enrico; Fugazza, Giuseppina; Matarese, Simona; Guardo, Daniela; Ballerini, Filippo ; Di Grazia, Carmen ; Raiola, Anna M.; Cagnetta, Antonia; Cea, Michele; Miglino, Maurizio ; Lemoli, Roberto M.; Gobbi, Marco.

In: British Journal of Haematology, 01.01.2018.

Research output: Contribution to journal › Article › peer-review

Minetto, P, Guolo, F, Clavio, M, Kunkl, A, Colombo, N, Carminati, E, Fugazza, G, Matarese, S, Guardo, D, Ballerini, F , Di Grazia, C , Raiola, AM , Cagnetta, A, Cea, M, Miglino, M , Lemoli, RM & Gobbi, M 2018, 'Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information', British Journal of Haematology. https://doi.org/10.1111/bjh.15106

Minetto, Paola ; Guolo, Fabio ; Clavio, Marino ; Kunkl, Annalisa ; Colombo, Nicoletta ; Carminati, Enrico ; Fugazza, Giuseppina ; Matarese, Simona ; Guardo, Daniela ; Ballerini, Filippo ; Di Grazia, Carmen ; Raiola, Anna M. ; Cagnetta, Antonia ; Cea, Michele ; Miglino, Maurizio ; Lemoli, Roberto M. ; Gobbi, Marco. / Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information. In: British Journal of Haematology. 2018.

@article{387c850b74cb49d5b15e193348bbb68b,

title = "Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information",

keywords = "Acute myeloid leukaemia, Flow cytometry, Fludarabine, Fludarabine, cytarabine, idarubicin, Minimal residual disease",

author = "Paola Minetto and Fabio Guolo and Marino Clavio and Annalisa Kunkl and Nicoletta Colombo and Enrico Carminati and Giuseppina Fugazza and Simona Matarese and Daniela Guardo and Filippo Ballerini and {Di Grazia}, Carmen and Raiola, {Anna M.} and Antonia Cagnetta and Michele Cea and Maurizio Miglino and Lemoli, {Roberto M.} and Marco Gobbi",

year = "2018",

month = jan,

day = "1",

doi = "10.1111/bjh.15106",

language = "English",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "John Wiley & Sons, Ltd (10.1111)",

}

TY - JOUR

T1 - Early minimal residual disease assessment after AML induction with fludarabine, cytarabine and idarubicin (FLAI) provides the most useful prognostic information

AU - Minetto, Paola

AU - Guolo, Fabio

AU - Clavio, Marino

AU - Kunkl, Annalisa

AU - Colombo, Nicoletta

AU - Carminati, Enrico

AU - Fugazza, Giuseppina

AU - Matarese, Simona

AU - Guardo, Daniela

AU - Ballerini, Filippo

AU - Di Grazia, Carmen

AU - Raiola, Anna M.

AU - Cagnetta, Antonia

AU - Cea, Michele

AU - Miglino, Maurizio

AU - Lemoli, Roberto M.

AU - Gobbi, Marco

PY - 2018/1/1

Y1 - 2018/1/1

KW - Acute myeloid leukaemia

KW - Flow cytometry

KW - Fludarabine

KW - Fludarabine, cytarabine, idarubicin

KW - Minimal residual disease

UR - http://www.scopus.com/inward/record.url?scp=85040868087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040868087&partnerID=8YFLogxK

U2 - 10.1111/bjh.15106

DO - 10.1111/bjh.15106

M3 - Article

AN - SCOPUS:85040868087

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

ER -